China Universal Asset Management »

Fate Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $26k 20k 1.26
2025-06-30 $26k 23k 1.12
2025-03-31 $18k 23k 0.79
2024-12-31 $40k 24k 1.65
2023-09-30 $5.4k 2.5k 2.12
2023-06-30 $6.1k 1.3k 4.76
2023-03-31 $7.6k 1.3k 5.70
2022-12-31 $10k 987 10.09
2022-09-30 $20k 909 22.00

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc-cl A Common Stock (GOOGL)
Meta Platforms Inc-class A Common Stock (META)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Gilead Sciences Common Stock (GILD)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl C Common Stock (GOOG)
Palantir Technologies Inc-a Common Stock (PLTR)
Applovin Corp-class A Common Stock (APP)

View all positions for China Universal Asset Management

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Group
Wilshire Associates
Johnson & Johnson
Acadian Asset Management
Geode Capital Management
Vestal Point Capital
Morgan Stanley
State Street Corporation
Dimensional Fund Advisors
Tang Capital Management
Goldman Sachs Group
Renaissance Technologies
AQR Capital Management

View all funds holding Fate Therapeutics